Sequenom pharmacogenetics, genomics, microarrays news

SQNM again restructured and will reduce its headcount by 29%, to 110 from 154. The cuts include CMO Andreas Braun and CFO Stephen Zaniboni. VP of Finance John Sharp is expected to assume the role of principal financial and accounting officer next quarter. SQNM said it will continue to focus on its genetic analysis business, which includes its MassARRAY products and its iPLEX multiplexing assay. ...